[1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches].
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D009946:Organothiophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009946:Organothiophosphorus Compounds; D003520:Cyclophosphamide
Primeras experiencias clínicas con isofosfamida. Resultados alejados de dos esquemas terapéuticos.